LBA41 Nivolumab (nivo) ± ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC)

Nicolas Girard, Julien Mazières, Josiane Otto, H. Léna, C. Lepage, Thomas Egenod, Denis Smith, J. Madelaine, L. Gérinière, Farid El Hajbi, Aurélie Ferru, Christelle Clément-Duchêne, Anne Madroszyk, Jérôme Desrame, Franck Morin, Alexandra Langlais, Pierre Michel, Christophe Louvet, Virginie Westeel, Thomas Walter